Clinical Trial Update: Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports results from Phase 2 and Phase 3 studies evaluating ranolazine for gastrointestinal motor function and pain in diarrhea-predo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea-predominant Irritable Bowel Syndrome
• Irritable Bowel Syndrome

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: Mayo Clinic | Conditions: Diarrhea Predominant Irritable Bowel Syndrome | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2016-02-08